RFB NO: ACDC/APPM/001/25 | Framework Agreement(s) (One-Envelope Bidding Process)
Issued on: 26th September 2025
Background
The Africa Centres for Disease Control and Prevention (Africa CDC) is a specialized technical institution of the African Union (AU), established in 2017 to strengthen the continent’s capacity to prevent, detect, and respond to disease threats. Headquartered in Addis Ababa, Ethiopia, Africa CDC serves as the continent’s public health authority, working with all 55 AU Member States to enhance health security and build resilient health systems. Its mandate covers disease surveillance, emergency preparedness and response, laboratory systems, and workforce development. Africa CDC also plays a central role in coordinating Africa’s collective response to epidemics and pandemics, promoting equitable access to vaccines, medicines, and diagnostics, and advancing the AU’s vision of health sovereignty and self-reliance. Through initiatives such as the Platform for Harmonized African Health Manufacturing (PHAHM) Africa CDC is shaping a future where the continent is better prepared to manage both current and emerging public health challenges.
At the 37th Ordinary Session of the Assembly of the African Union, held on 18 February 2024, the Heads of State and Government officially decided to establish the African Pooled Procurement Mechanism (APPM) and directed Africa CDC to implement the modalities for full operationalization of the mechanism immediately, aiming to improve affordability, availability, and equitable access to essential medical supplies across all AU Member States. Africa CDC with the support of development partners, has been working on the design of the Pooled Procurement Mechanism which is deigned to take a phased approach with few products identified as a start up phase of the APPM.
In consultation with Member States and Reginal Economic Communities (RECs) and through internal consultation the following key categories have been identified for the start up phase of the APPM RMNH Medicines: Oxytocin Injection 10 IU/ ml, Carbetocin Injection (Heat-Stable) 100 µg/mL, Amoxicillin Dispersible Tablets 125 mg ),Amoxicillin Dispersible Tablets 250 mg (scored),Magnesium Sulphate Injection 50 % (10 mL and 2ml ),Misoprostol 200 µg Tablets (Sublingual), Levonorgestrel – Releasing Contraceptive Implant – 1 rod (150 mg LNG per rod; total 150 mg).Clomiphene Citrate Tablets 50 mg, Labetalol Tablets 200 mg, and Zinc Sulfate Dispersible Tablets 20 mg.